Chewable Tablets Settlement, Check If You’re Eligible

The lawsuit claims that Defendants misrepresented the amount of fluoride contained in the Chewable Tablets from a period beginning at some point in 2007, manufacturing the Chewable Tablets with only approximately 44% of the fluoride ion claimed on the label and package insert. A proposed $15.5 million settlement has been reached with Endo Health Solutions.

-Multivitamin with Fluoride Chewable Tablets  qualitest   Google Search.jpeg

Who’s Eligible?

You are included if you or your company paid for Chewable Tablets branded “Qualitest Pharmaceuticals,” “Vintage Pharmaceuticals,” or “Physicians Total Care,” purportedly containing doses of fluoride of 1.0 mg, 0.5 mg, or 0.25 mg between October 31, 2007 and December 31, 2015.

How Much Do I Get?

All consumer Submitted Claims up to $250 will be paid (pro rata) whether the Class member provides supporting documents or not, unless the claim would create a payment that is duplicative of an Identified Claim. For consumer Submitted Claims above $250, consumer claimants will be required to submit documentation supporting their claim, and if they do so, they will be paid (pro rata)

You must submit a claim by April 17, 2017


Settlement Details


 

Tags:

3 responses to “Chewable Tablets Settlement, Check If You’re Eligible”

  1. Hi my name is Dorothy wease I purchased tablets and liquid fluoride through a pharmacy in between these dates I want to talk to someone on how I go about getting the documents needed please call me asap at 541-679-5632 contact Dorothy Wease

    1. You should look for contact numbers on the settlement website

  2. […] Chewable Tablets Settlement, Check If You’re Eligible by Danny Deal Guru. Never know who will be eligible I guess. […]

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent Articles

Homepage | About Us | Privacy Policy | Disclosure Policy

Discover more from Danny the Deal Guru

Subscribe now to keep reading and get access to the full archive.

Continue reading